Tuesday, November 15, 2011 3:13:10 PM
Today’s agreement on the Court-ordered bond and related liabilities does not in any way change NVS-MNTA’s agreement on dividing the proceeds from sales of generic Lovenox.
Self evidently true - but probably equally true that Momenta wouldn't agree to take on a percentage liability significantly different than their expected benefit if MNTA/NVS prevail. I.e. if MNTA expects to get only 10% of the expected NPV of additional cash flow when NVS/MNTA prevail then I wouldn't expect them to take on 50% of the liability should NVS/MNTA lose.
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT) • BLOZF • Mar 16, 2026 8:37 AM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
